Insider Trading & Ownership of Atlas Venture Fund XII, L.P.

Location
Cambridge, MA
Summary
The estimated value of insider holdings of Atlas Venture Fund XII, L.P. is at least $45,394,226 dollars as of 07 Aug 2025. Atlas Venture Fund XII, L.P. is the 10%+ Owner of Aerovate Therapeutics, Inc. and owns shares of Jade Biosciences, Inc. (JBIO) stock worth about $45.39M.
Signature
Atlas Venture Fund XII, L.P. By: Atlas Venture Associates XII, L.P., Its: General Partner By: Atlas Venture Associates XII, LLC, Its General Partner, By: /s/ Ommer Chohan, its CFO
All Insider Reports
All Insider Reports

Notify me when Atlas Venture Fund XII, L.P. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Atlas Venture Fund XII, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
JBIO Aerovate Therapeutics, Inc. 10%+ Owner $45,394,226 15 Jul 2022
VIGL Vigil Neuroscience, Inc. 10%+ Owner $0 05 Aug 2025

Insider Transactions Reported by Atlas Venture Fund XII, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.